Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.
Wachstum
Das Unternehmen befindet sich in einer Wachstumsphase, wobei das aktuelle Jahreseinkommen insgesamt 5.72M USD beträgt.
Unterbewertet
Die aktuelle PB1 des Unternehmens liegt bei 1.702, im niedrigen 3-Jahres-Perzentilbereich.
Institutionelle Verkäufe
Die neuesten institutionellen Bestände sind 711.27K Aktien, was einen Rückgang von 16.11% im Vergleich zum Vorquartal darstellt.